Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study

References

• Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000; 42(1 Pt 2)4–7
   PubMed Web of Science ®Google Scholar
• Cockerell CJ. Pathology and pathobiology of the actinic (solar) keratosis. Br J Dermatol. 2003; 149(suppl 66)34–6
   Google Scholar
• Cockerell CJ, Wharton JR. New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma). J Drugs Dermatol. 2005; 4: 462–7
   PubMedGoogle Scholar
• Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000; 42(1 Pt 2)8–10
   PubMedGoogle Scholar
• Fu W, Cockerell CJ. The actinic (solar) keratosis. A 21st-century perspective. Arch Dermatol. 2003; 139: 66–70
   PubMed Web of Science ®Google Scholar
• Anwar J, Wrone DA, Kimyai-asadi A, Alam M. The development of actinic keratosis into invasive squamous cell carcinoma: Evidence and evolving classification schemes. Clin Dermatol. 2004; 22: 189–96
   PubMed Web of Science ®Google Scholar
• Czarnecki D, Meehan CJ, Bruce F, Culjak G. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg. 2002; 6: 207–9
   PubMed Web of Science ®Google Scholar
• Jorizzo JL. Current and novel treatment options for actinic keratosis. J Cutan Med Surg. 2004; 8(supp 3)13–21
   Google Scholar
• Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol. 2000; 42(1 Pt 2)25–8
   PubMedGoogle Scholar
• Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2004; 30(2 Pt 2)264–71
   Google Scholar
• Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y. Topical treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronan gel. Br J Dermatol. 2002; 146: 94–100
   PubMed Web of Science ®Google Scholar
• Wolf JE, Taylor JR, Tschen E, Kang S. Topical 3% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol. 2001; 40: 709–13
   PubMed Web of Science ®Google Scholar
• Del Rosso J, Walsh K. A randomized, single center, double-blind, placebo-controlled study to evaluate the safety and the efficacy of 3% diclofenac gel in the topical treatment of outpatients with actinic keratoses (clinical trial summary, data on file). Bioglan Pharma Inc, Malvern, PA 2001
   Google Scholar
• Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: Outcome and comparison of light sources. Photodermatol Photoimmunol Photomed. 2003; 19: 134–41
   PubMed Web of Science ®Google Scholar
• Kauffmann R, Spelman L, Weightman W, Reifenberger J, Szeimies RM, Verhaeghe E, et al. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol. 2008; 158: 994–9
   Google Scholar
• Wang I. Photodynamic therapy and laser-based diagnostic studies of malignant tumours. Lund University, LundSweden 1999
   Google Scholar
• Fijan S, Hönigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol. 1995; 133: 282–8
   PubMed Web of Science ®Google Scholar
• Oosten van EJ, Kuijpers DIM, Thissen MRTM. Different pain sensations in photodynamic therapy of nodular basal cell carcinoma. Results from a prospective trial and a review of literature. Photodiagn Photodyn Ther. 2006; 3: 61–8
   Google Scholar
• Wiegell SR, Skiveren J, Philipsen PA, Wulf HC. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol. 2008; 158: 727–33
   PubMed Web of Science ®Google Scholar
• Cottrell WJ, Paquette AD, Keymel KR, Foster TH, Oseroff AR. Irradiance-dependent photobleaching and pain in ×-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res. 2008; 14: 4475–83
   PubMed Web of Science ®Google Scholar
• Jarvis B, Figgitt DP. Topical 3% diclofenac in 2.5% hyaluronic acid gel. A review of its use in patients with actinic keratoses. Am J Clin Dermatol. 2003; 4: 203–13
   PubMed Web of Science ®Google Scholar
• Carroll CL, Feldmann SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: Commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004; 51: 212–16
   PubMed Web of Science ®Google Scholar
• Pirard D, Vereecken P, Melot C, Heenen M. Three percent of diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: A meta-analysis of the recent studies. Arch Dermatol Res. 2005; 297: 185–9
   PubMedGoogle Scholar
• Gilbert DJ. Treatment of actinic keratoses with sequential combination of 5-fluorouracol and photodynamic therapy. J Drugs Dermatol. 2005; 4(2)161–3
   Google Scholar
• Mastrolonardo M. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses. Clin Exp Dermatol. 2009; 34: 33–5
   PubMed Web of Science ®Google Scholar
• Devirgilliis V, Panasiti V, Curzio M, Gobbi S, Rossi M, Roberti V, et al. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream. Dermatol Online J. 2008; 14(2)25
   Google Scholar
• Winters U, Daayana S, Lear JT, Tomlinson AE, Elkord E, Stern PL, et al. Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res. 2008; 14: 5292–9
   PubMed Web of Science ®Google Scholar
• Theelen T, Hoyng CB. Intravenous diclofenac as prophylactic treatment for verteporfin-associated low back pain. Eur J Ophthalmol. 2008; 18: 805–8
   Google Scholar
• Pece A, Vadala M, Manzi R, Calori G. Back pain after photodynamic therapy with verteporfin. Am J Ophthalmol. 2006; 141: 593–4
   Google Scholar